For HCPs Only
Recent Clinical Updates
Loading latest clinical updates

Clinical Intelligence & Drug Records for US-Licensed Practitioners

The integrated, institutional-grade registry trusted by US-licensed practitioners for evidence-based clinical data, drug information, and peer-reviewed drug updates.

Drug Update Briefing

Weekly drug approvals, safety updates, and specialty coverage for healthcare professionals.

Clinical Resources

Drug updates, reference data, and specialist-led coverage.

Recent Clinical Updates

Latest Drug & Specialty Updates

View All

Specialty Coverage

Therapeutic-area updates for clinical review.

All Specialties

Drug Information

FDA drug records and prescribing context.

Review drug records, NDC references, dosage tools, and interaction resources alongside clinical coverage.

Clinical Coverage

Additional Drug Updates

Rheumatology

FDA Approves First Interchangeable Biosimilars for Rheumatoid Arthritis: Cost Savings and Formulary Implications

May 29|3 min read|By Dr. Deepak Nair
Pulmonology

WHO Releases 2026 Smoking Cessation Guidelines: Cytisinicline vs Varenicline vs NRT vs Bupropion

May 29|3 min read|By Dr. Nikhil Chatterjee
Oncology

Zanubrutinib and Acalabrutinib: New Treatment Paradigms for Mantle Cell Lymphoma

May 29|3 min read|By Dr. Rahul Verma
Infectious Disease

COVID-19 Treatment Options: Comparing Ensitrelvir, Paxlovid, and Lagevrio

May 29|3 min read|By Dr. Simran Kohli
Cardiology

Baxdrostat Reduces Resistant Hypertension: New Treatment Algorithm for 2026

May 29|3 min read|By Dr. Kavya Sharma
Gastroenterology

FDA Approves New Biologics Algorithm for Ulcerative Colitis: Golimumab, Vedolizumab, Upadacitinib, and More

May 29|3 min read|By Dr. Sanjay Iyer
Infectious Disease

CDC Updates Hepatitis B Vaccination Guidelines: Universal Vaccination for Adults 19-59 and Catch-Up for Those Over 60

May 29|3 min read|By Dr. Simran Kohli
Infectious Disease

FDA Approves Doravirine and Islatravir for HIV-1: Once Daily Two-Drug Regimen

May 26|3 min read|By Dr. Simran Kohli
Neurology

FDA Submission of CNM-Au8 for ALS: NfL Surrogate Endpoint Considered

May 26|3 min read|By Dr. Aditi Kulkarni
Pulmonology

Biologics for Severe Asthma: Comparing Mepolizumab, Benralizumab, Dupilumab, Tezepelumab, and Depemokimab

May 26|3 min read|By Dr. Nikhil Chatterjee
Cardiology

FDA Approves Semaglutide for PAD: STRIDE Trial Shows Improved Walking Distance

May 26|3 min read|By Dr. Kavya Sharma
Endocrinology

FDA Accepts Afrezza for Pediatric Diabetes: First Needle-Free Insulin for Ages 4 and Up

May 26|3 min read|By Dr. Amit Desai
Rheumatology

Biosimilars for TNF Inhibitors: Cost-Effective Options for Rheumatology in 2026

May 26|3 min read|By Dr. Deepak Nair
Pharmacology

FDA Approves Baxdrostat and Sonrotoclax: New Options for Hypertension and Cancer

May 26|3 min read|By Editorial Team
Psychiatry

CTx-1301 Triple Release Shows Promise Against Concerta, Adderall XR, and Vyvanse in ADHD Treatment

May 26|3 min read|By Dr. Mohit Joshi
Rare Disease

FDA Approves Navepegritide for Achondroplasia: 1.5 cm Height Increase in Children

May 21|3 min read|By Editorial Team
Rare Disease

FDA Approves Tividenofusp Alfa for Hunter Syndrome: New Enzyme Replacement Therapy

May 21|3 min read|By Editorial Team
Neurology

Leucovorin Updates CSF Folate Treatment Protocol for Cerebral Folate Deficiency

May 21|3 min read|By Dr. Vikram Patel
Dermatology

FDA Approves Icotrokinra for Moderate-to-Severe Plaque Psoriasis: Oral IL-23 Antagonist Launches New Treatment Option

May 21|3 min read|By Dr. Divya Agarwal
Neurology

FDA Approves Atogepant for Episodic Migraine Prevention: 50% Reduction in Migraine Days

May 21|3 min read|By Dr. Aditi Kulkarni
Oncology

FDA Approves Datopotamab Deruxtecan for EGFR-Mutated NSCLC: 45% ORR in Prior Therapy Patients

May 21|3 min read|By Dr. Rahul Verma
Cardiology

Aficamten Reduces Symptoms by 30% in Obstructive HCM: 2025 Clinical Algorithm Update

May 21|3 min read|By Dr. Arjun Sharma
Endocrinology

Tirzepatide and Semaglutide: New Weight Loss Protocols for Obesity Management

May 21|3 min read|By Dr. Amit Desai